Month: January 2022
Medicare and Medicaid place restrictions on new Alzheimer’s drug, Aduhelm (aducanumab)
An important decision has been made about a controversial new drug to treat Alzheimer's disease.
Culture-Bound Psychosomatic Syndromes
In her book Sleeping Beauties, neurologist Suzanne O'Sullivan travels the world to investigate fascinating stories of mass psychogenic illness where social and cultural factors result in symptoms that give voiceless people a way to be heard.
Why are physicians threatened by efforts to report doctors to their state medical board for COVID-19 misinformation?
It's not "cancel culture" to delicense physicians promoting dangerous misinformation about COVID-19. It's quality control. Why do so many physicians think it is?
A Modest Proposal: Schools Must Open With Untested, Unmasked, Unvaccinated Children
Kids don’t need Covid-19 vaccines to return to school and the downsides of masking young students are real.
Department of Justice prioritizes prosecution of clinical trial fraud, but systemic reform is needed
The U.S. Department of Justice recently announced it is aggressively pursuing clinical trial fraud, where unethical players create fictional trial participants, steal the drugs under study, and fabricate results. But systemic reform of the clinical drug trial system is needed to halt those who endanger public safety with bogus trials.
Breakthrough Heart Xenotransplantion from Pig
In a first, a bioengineered pig heart is transplanted into a human donor, indicating we are on the threshold of a game-changing option for organ transplantation.
The Blu Room
Blu Rooms are an expensive way to relax. The testimonials and the medical history of the inventor are not believable. No science, but good for a laugh.
Substack: Where quacks and antivaxxers all go now
With social media companies like Twitter and Facebook/Meta deplatforming those spreading misinformation, COVID-19 quacks, antivaxxers, and conspiracy theorists are flocking to Substack, where they can monetize their misinformation while Substack profits.
The Misinformation Dilemma
Is there a workable solution to the social media dilemma?